Section | Acronym | Question |
---|---|---|
External validity | Q1_EV | How confident are we that the assessment endpoint can be used to inform the risk assessment of bees? |
Q2_EV | Are the test organisms exposed to either flupyradifurone or acetamiprid in isolation (without any other active substances)? | |
Q3_EV | Are the tested organisms relevant for Europe? | |
Q4_EV | Is the study location representative of any EU biogeographical region? | |
Q5_EV | Is the study setting representative of an EU agricultural landscape? | |
Q6_EV | Do the experimental conditions represent a reasonable worst‐case for both exposure and possible triggering of the effects? | |
Internal validity | Q1_IV | Is the origin of the tested organism trustable? |
Q2_IV |
Were the test organisms properly acclimatised to the study setup before the exposure started? |
|
Q3_IV | Are the test organisms healthy and stress‐free at the start of the experiment? | |
Q4_IV | Is the methodology used (including the experimental setup) for measuring the assessment endpoint reliable? | |
Q5_IV | Is the negative control free from contamination and performing adequately? | |
Q6_IV | Are the treatments and exposure levels well characterised? | |
Q7_IV | Is the test item clearly identified and characterised? | |
Q8_IV | Is the duration of the test appropriate to characterise the assessment endpoint? | |
Q9_IV | Is the presence of other stressors checked and accounted for? | |
Q10_IV | Is the derivation of the measured endpoint(s) performed with sound statistical methods? | |
Precision | Q1_PR | Are the sample size and replication appropriate? |